Ethics bureaucracy: a significant hurdle for collaborative follow-up of drug effectiveness in rare childhood diseases

Arch Dis Child. 2012 Jun;97(6):561-3. doi: 10.1136/archdischild-2011-301175. Epub 2012 Feb 22.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Clinical Trials as Topic / ethics*
  • Ethics, Medical
  • Europe
  • Humans
  • Pediatrics / ethics*
  • Rare Diseases / drug therapy*
  • Registries*